OS Therapies Receives EMA's Advanced Therapy Medicinal Product Designation For OST-HER2 In Pulmonary Recurrence Of Resected Osteosarcoma, Opening Conditional Marketing Authorisation Pathway

Benzinga Newsdesk www.benzinga.com Positive 92.2%

Neg 0% Neu 0% Pos 92.2%

Comments

No comments yet. Be the first!